September 30, 2009
to drug companies asking them to put their drug patents in the pool.
New York/London, September 30, 2009 – The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today called on nine of the world's largest pharmaceutical companies to help accelerate the availability of new treatments for millions of people living with HIV/AIDS, by pooling their patents on a list of key HIV medicines.
"It’s a simple idea: companies share their knowledge in return for fair royalty payments,” said Michelle Childs, director of policy and advocacy at MSF’s Campaign for Access to Essential Medicines. "But it has the potential to transform companies’ approaches to access to HIV medicines and foster innovation in a way that marks an alternative to the confrontation and litigation of the past.”
Some of the drugs identified by MSF to be essential for the pool, based on its field experience, are recommended by the World Health Organization for use in developing countries.
MSF is launching an e-mail writing campaign calling on Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline, Merck & Co, Pfizer, and Sequoia Pharmaceuticals to meet the promise afforded by this mechanism and put their HIV drug patents in the pool.
© 2013 Doctors Without Borders/Médecins Sans Frontières (MSF)